RSS Feed
CuraGen-Bayer Deal Shows Genetic Information Is Becoming a Commodity
Investors are demanding more from companies that mine the human genome.
04:22PM 01/16/01
CV Therapeutics Plunges on Drug Development Setback
Expanding a trial could tack six months on to Ranolazine's development.
02:15PM 01/05/01
Biotechs Cheer, Drugs Jeer Rate Cut
But observers doubt a sustained exodus from drug stocks will occur.
06:06PM 01/03/01
Biotechs Face New Year Hangover From IPO Overhang
A huge rush of stock will come to market as six-month lockups expire.
11:40AM 12/26/00
Insider Selling Has Some Wondering What's Next at American Home
The drugmaker has been plagued by recalls and lawsuits, but its stock has jumped as tech swoons.
10:14AM 12/26/00
New Year, New Rules: Drugs Sounding Good to Investors About Now
The pharmaceuticals' strong cash flows look appealing as tech panic spreads.
06:47PM 12/20/00
Biotech Start-Up Banks on Big Names as IPO Approaches
GMP boasts an ample supply of biotech stars but little in terms of revenue or product. Is this market ready for this deal?
11:49AM 12/19/00
Amgen's Seal of Approval Boosts Immunomedics
A deal for a late-stage cancer drug lights a fire under both biotech stocks.
02:23PM 12/18/00
FDA Panel Backs Millennium-Ilex-Schering Cancer Drug
The drug marks the first marketed product for Millennium and Ilex.
03:07PM 12/14/00
Maxim Heading Toward Minimum After FDA Panel Rout
The company's lead drug looks unlikely to be approved in any cancer indication, an analyst says.
06:52PM 12/13/00
Connect with TheStreet